Robotics IPO craze
The great robot IPO rush
Thirty-plus Chinese robot makers are sprinting to go public at once. Unitree just priced at $9 billion. Here's the whole field — on which exchange, at what valuation, with every company's funding history and early backers one tap away.
On August 6, 2026, Unitree priced its Shanghai IPO at 150.8 yuan a share — about $9 billion — becoming the first humanoid-robot maker to list on mainland China. It won't be alone for long. Behind it: 30 to 50 Chinese embodied-AI startups have disclosed or signalled listing plans, and Hong Kong alone is processing 500+ applications.
Sections below are cards — tap a header to open or close it.
Already trading
The robot & reducer names you can actually buy
Only a handful of pure robot plays are public yet — the humanoid leaders (Unitree, AgiBot) are brand-new or private. But the picks-and-shovels layer, the reducer and motion suppliers, has been listed for years. Tap a range to reshape the mini charts.
The IPO pipeline
Valuation · market · status — tap a company for funding & investors
The full field, priced to rumour. Valuations move weekly — best public reads as of mid-August 2026. Tap or hover any company to reveal how much it raised, in which rounds, and who got in early. Chinese names and pinyin are shown for each.
Why they're all running at once
Four forces pushing everyone to the exit together
Capital is the weapon. Scaling humanoid production burns cash. "Listing is a must," as one founder put it. A float banks a war chest before rivals do — in a 140-company field, whoever raises first can out-spend the rest into consolidation.
Beijing holds the door open. Unitree cleared review in a record 104 days. China marked "embodied AI" strategic, with $26B+ in state and local funds since late 2024, free land, rent cuts and procurement pipelines. Fast-tracked listings are policy.
Lock the valuation before hype cools. Private marks are sky-high (Figure AI reportedly $39B on near-zero disclosed revenue). Chinese firms want a public benchmark banked while appetite is hot — Unitree's secondary chatter already ran toward $14.8B.
The export-control clock. New US rules could bar future Chinese humanoids from the American market. Raising domestic capital now hedges against being locked out later — most are pivoting to home and allied demand anyway.
The edge over the West & Japan
Why China thinks it can win — and where it's still behind
The case is almost entirely speed and cost, not AI sophistication. Chinese firms shipped roughly 10× more humanoids than US firms in 2025 and filed 7,705 humanoid patents in five years to America's 1,561. The gap isn't invention — it's manufacturing.
🇨🇳 China's edge
- 20–30% annual cost cuts — a Unitree G1 costs less than a used car
- Complete domestic supply chain — motors, reducers, sensors all local
- Subsidies — ~10% of each robot's price paid to early buyers
- Fast-tracked capital — 104-day IPO reviews, $26B state funds
- Real deployment — units on BYD, Zeekr, NIO lines already
🇺🇸🇪🇺🇯🇵 Where the West/Japan lead
- AI & foundation models — US still ahead on the "brain"
- Precision components — Japan owns the highest-spec reducers
- High-reliability niches — aerospace, medical, defense (Europe)
- Deep private capital — Figure AI's $39B dwarfs Chinese raises
- Trust & standards — Western buyers wary of data/security
The rush is China converting a manufacturing lead into financial firepower before the window closes. Unitree is the benchmark; a dozen more are queued behind it. Watch whether the public valuations survive their first earnings calls — the test private marks never have to take.
Sources & further reading
Prices, valuations and funding figures are approximate, from public sources on the dates shown, and change constantly. IPO details subject to change and regulatory approval. Analysis, not investment advice.
